Galderma Raises Full-Year Sales Guidance After Strong H1 2024 Performance
Galderma's Financial Results and Updated Outlook
Strong First-Half 2024 Sales Growth
ZURICH, July 23 (Reuters) - Swiss skincare firm Galderma on Thursday reported a 24.6% jump in sales in the first half of the year and nudged up its full-year net sales growth guidance, citing double-digit growth in international markets and the U.S.
First-Half Sales Figures
First-half sales rose to $3.13 billion, and the company now expects net sales to grow 19-21% this year from a previous target of 17-20%.
Growth Drivers by Region and Product Category
The Zug-based company said it had registered double-digit growth in both international markets and the United States as well as in all product categories, chiefly driven by volume and complemented by favourable mix.
Full-Year Guidance and Market Considerations
Impact of U.S. Tariffs and Market Volatility
Galderma said its full-year guidance factors in manageable exposure to announced U.S. tariffs, along with the ability to absorb potential consumer demand deterioration in the second half, given a volatile political and macroeconomic environment.
Editorial Note
(Writing by Dave Graham, Editing by Linda Pasquini)
